CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting

The Value of CASUS vs. APACHE II in Predicting Mortality Among Patients Undergoing Coronary Artery Bypass Grafting

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05026437

Acronym

CASUS

Enrollment

204

Registered

2021-08-30

Start date

2019-01-02

Completion date

2019-04-10

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Grafting, Mortality

Keywords

cardiac surgery score, mortality, ICU

Brief summary

The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.

Detailed description

Patients undergoing coronary artery bypass grafting will prospectively studied after the admission to the cardiac intensive care unit. Data on the preoperative condition, intraoperative parameters, and postoperative course will collected. CASUS and APACHE II scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of stay in the cardiac surgical intensive care unit and in the hospital.

Interventions

OTHERCardiac surgery score and APACHE II scoring

Cardiac surgery score and APACHE II will calculated on the first postoperative day.

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Undergoing coronary artery bypass grafting * Over 18 years of age * Staying at least 24 hours in the cardiac intensive care unit

Exclusion criteria

* Emergency surgery

Design outcomes

Primary

Measure	Time frame	Description
Mortality at 7 days	7 days	Mortality in the first 7 days after surgery
Mortality at 30 days	30 days	Mortality in the first 30 days after surgery

Secondary

Measure	Time frame	Description
Length of stay in the cardiac intensive care unit	Up to 3 months (Through study completion)	Only the length of the initial stay in the cardiac intensive care unit up to 3 months
Length of the stay in the hospital	Up to 3 months (Through study completion)	It includes the period from surgery to discharge

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026